Pharmacokinetic and Pharmacodynamic Interaction of DWP16001, an SGLT2 Inhibitor, with Gemigliptin and Metformin in Healthy Adults.

Published in: British journal of clinical pharmacology (2022)

The results suggest that the DWP16001 could be added to metformin and gemigliptin combination therapy without dose adjustment.

Keyphrases